Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T22:18:26.552Z.
Calculation as of: 2026-10-06T22:18:26.552Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cae73e0f7d7453288b6b30bb28ae33caa2dcc4a3490ac3f0933bc7bc3ce0e433
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Palvella Therapeutics, Inc.
Market Cap
$1.84B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.83B
Price/FCF Ratio
11.58
TTM Avg
12.50
3Y Avg
25.31
5Y Avg
28.24
Market Cap
$1.83B
Price/FCF Ratio
N/A
TTM Avg
19.70
3Y Avg
19.70
5Y Avg
19.70
Market Cap
$1.81B
Price/FCF Ratio
24.47
TTM Avg
31.22
3Y Avg
46.66
5Y Avg
45.78
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palvella Therapeutics, Inc. (PVLA) | $1.84B | N/A | N/A | N/A | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 11.58 | 12.50 | 25.31 | 28.24 |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | N/A | 19.70 | 19.70 | 19.70 |
| Immunome, Inc. (IMNM)vs › | $1.85B | N/A | 53.35 | 53.35 | 53.35 |
| Azenta, Inc. (AZTA)vs › | $1.81B | 183.56 | 56.48 | 95.26 | 92.20 |
| Novavax, Inc. (NVAX)vs › | $1.86B | N/A | 22.72 | 85.02 | 85.02 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 24.47 | 31.22 | 46.66 | 45.78 |
| Xencor, Inc. (XNCR)vs › | $1.81B | N/A | 228.23 | 155.55 | 119.73 |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | N/A | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | N/A | 547.75 | 444.15 | 642.22 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
